Hormone replacement therapy and endometrial cancer in Ontario, Canada
- 1 April 2000
- journal article
- research article
- Published by Elsevier BV in Journal of Clinical Epidemiology
- Vol. 53 (4), 385-391
- https://doi.org/10.1016/s0895-4356(99)00192-4
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Agreement of Self-Reported Use of Menopausal Hormone Replacement Therapy with Physician ReportsEpidemiology, 1999
- Menopausal Hormone Use and Endometrial Cancer, by Tumor Grade and InvasionEpidemiology, 1998
- Hormone Replacement Therapy and Endometrial Cancer: Are Current Regimens Safe?JNCI Journal of the National Cancer Institute, 1997
- Estrogen-Progestin Replacement Therapy and Endometrial CancerJNCI Journal of the National Cancer Institute, 1997
- Controversies Surrounding Estrogen Use in Postmenopausal WomenAnnals of Pharmacotherapy, 1997
- Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal womenThe Lancet, 1997
- Preoperative evaluation and staging of endometrial cancerCancer, 1995
- Hormone replacement therapy and endometrial cancer risk: A meta-analysisObstetrics & Gynecology, 1995
- A two-year double-blind controlled study of the clinical effect of combined and sequential postmenopausal replacement therapy and steroid metabolism during treatmentMaturitas, 1993
- PROGESTAGEN USE IN POSTMENOPAUSAL WOMENThe Lancet, 1988